Theratechnologies juggles multiple suitors, including $255M offer from CDMO Future Pak
The HIV-focused biopharma has received its latest bid from CDMO Future Pak for a cool $255 million, but the drugmaker had to disclose it is currently in negotiations with another suitor.
